Best Grants for Rare Diseases in New Hampshire

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) aims to enhance research capabilities in eligible states by increasing the number of university researchers and institutions conducting relevant science and engineering research. Sponsored by the Department of Defense, this program will fund multiyear awards to promote research aligned with national security needs. Applications require a multi-stage submission process, emphasizing early registration and timely proposal submissions.

The ARS Resident Research Grant aims to foster innovative research in rhinology, supporting residents engaged in basic, translational, or clinical projects. Applicants must collaborate with a preceptor and obtain departmental approval. Eligible residents in U.S. or Canadian programs can apply, ensuring that their projects align with the standards of the American Rhinologic Society. This grant does not cover salary for the Principal Investigator but allows funding for assistants.

The Charles D. McArthur Memorial Scholarship recognizes outstanding third and fourth-year students in accredited respiratory therapy programs. Funded by the American Respiratory Care Foundation, this award honors Charlie McArthur's legacy as a dedicated educator in respiratory care. Recipients may receive up to $1,000, including a certificate, travel, and registration for AARC Congress. Preference is given to Native American students or those from Minnesota, fostering diversity in the field of respiratory therapy.

The NBRC Gareth B. Gish Memorial Postgraduate Education Recognition Award, offered by the American Respiratory Care Foundation, honors the legacy of Gareth B. Gish, a pioneer in respiratory care. This award supports respiratory therapists pursuing advanced degrees, providing up to $5,000 in funding, along with recognition, airfare, lodging, and Congress registration. Established in 1999, it seeks to nurture future leaders in the field, continuing Mr. Gish's commitment to education and excellence in respiratory care.

Respiratory therapists pursuing advanced degrees can receive up to US $5,000 for postgraduate education from the American Respiratory Care Foundation, including applicants from New Hampshire. With a mission to promote respiratory health, this award supports tuition and related educational costs plus recognition, travel, lodging, and registration for the AARC Congress.

Researchers conducting respiratory care and airway management studies in New Hampshire and across the U.S. can receive support for original university hospital research. Grants from American Respiratory Care Foundation help respiratory diseases and systems investigators attend the AARC Congress with airfare, lodging, registration, and recognition for high-quality accepted abstracts.

Graduate students and other qualified investigators conducting respiratory care education or credentialing research can apply for up to US $5,000 in support, plus conference travel benefits. Grants from American Respiratory Care Foundation help New Hampshire respiratory health projects and rare disease–related studies that fit its respiratory diseases and systems focus advance their work.

Nonprofit organizations conducting respiratory care research, including work relevant to rare respiratory diseases in New Hampshire, can apply for the American Respiratory Care Foundation’s Parker B. Francis Respiratory Research Grant. Awards up to US $10,000 support projects where respiratory therapists or technicians are meaningfully involved, with physicians or respiratory care practitioners serving as principal investigators.

Focused on respiratory care research, the American Respiratory Care Foundation invites New Hampshire nonprofit organizations to apply for support of projects in respiratory care and cardiopulmonary medicine. Eligible projects must meaningfully involve respiratory therapists or technicians as investigators and may receive up to US $10,000 to supplement other research funding, including work related to rare respiratory diseases.

Early-career respiratory care researchers focusing on pediatric respiratory therapy can receive up to US $5,000 to support their first research projects and professional development. Grants from American Respiratory Care Foundation help New Hampshire and other U.S. investigators fund mentoring, hands-on research experience, and small equipment or supplies for respiratory diseases and systems studies.

Health care professionals working in respiratory diseases and systems in New Hampshire and worldwide can apply for an international fellowship that funds a structured, up-to-20-day observational visit in the U.S. The American Respiratory Care Foundation covers domestic lodging, food allowance, local transportation, and AARC Congress registration for fellows committed to advancing respiratory care.

Early-stage pulmonary fibrosis researchers, including post-docs and junior faculty in fields like respiratory diseases, can apply for Pulmonary Fibrosis Foundation’s PFF Scholars awards of US $100,000 to support mentored research and career development. Eligible investigators in New Hampshire may benefit if they meet degree, appointment, and independence criteria.

Biomedical researchers and clinician-scientists conducting NHLBI-related clinical trials can access career transition funding that supports intramural and extramural research phases, including work relevant to respiratory diseases in New Hampshire. US Dept. of Health & Human Services: National Institutes of Health supports postdoctoral fellows moving from NHLBI intramural positions to independent roles at eligible U.S. institutions.

Research institutions and biomedical organizations working on leprosy can apply for The New York Community Trust’s Heiser Program, with awards from US $87,500 - US $250,000. Projects may include diagnosis, treatment, transmission blocking, or surveillance research, and New Hampshire rare disease researchers studying leprosy-related dermatological or neurological impacts may be eligible.

Early-career clinical or scientific investigators conducting innovative sarcoidosis research at U.S. institutions can receive fellowship support to build skills and advance patient care. With a mission to advance sarcoidosis research, Foundation for Sarcoidosis Research provides international applicants with US $150,000 over two years for fellow compensation and mentored career development.

Early-career research scientists at academic or research institutions in eligible low- and middle-income countries can apply for National Institutes of Health Emerging Global Leader Award support to conduct mentored clinical research. Grants from NIH help investigators working on cancer, respiratory, neurological, mental health, or related diseases, including rare respiratory conditions, which may benefit New Hampshire-focused collaborators.

Early-career research scientists at academic or research institutions in eligible low- or middle-income countries can apply for the Emerging Global Leader Award to support mentored health-related research and career development. Offered by the National Institutes of Health, this award provides approximately US $140,000 and may benefit investigators studying respiratory or other rare disease-related conditions, including work connected to New Hampshire partners.

With a mission to advance nonmalignant hematology research, the National Institutes of Health provides New Hampshire medical and research institutions with R01 funding for basic and early translational studies. Projects may address hematological systems alongside related areas such as aging, cardiovascular, kidney, endocrine, respiratory, digestive, diabetes, and sleep disorders, which may benefit some rare disease programs.

The IRSS RIFM Special Award for Inhalation Toxicology offers a $500 prize for trainees contributing to inhalation toxicology research. Sponsored by the Society of Toxicology, this award encourages innovative evaluations of inhaled toxicants, exposure science advancements, and risk assessment research. Applicants must submit a one-page summary of their work and a pending abstract for presentation at the SOT Annual Meeting, alongside a mentor's support letter. This award aims to promote excellence in the field.

The Community Foundation of Shelby County

Our Mission

To inspire donor generosity and transform it into meaningful, lasting impact through charitable gifts.

Our Vision

To be the primary partner for donors who want to advance the community’s quality of life and capacity for excellence.

Heidi Norris Scholarship

Auglaize, Shelby or Mercer County residents majoring in Respiratory Therapy or a closely related field who are one year removed from high school, surpassed college freshman status and, have maintained a college GPA of not less than 2.5, and who are pursuing an Associate’s, Bachelor’s, or Master’s degree.

Selection based upon:

Financial need, academic ability, community and school service, and recommendations.

Awards

• One $1,500 scholarship

The Patient-Centered Outcomes Research Institute (PCORI) intends to release an Implementation of Findings From PCORI's Research Investments PCORI Funding Announcement (PFA) on Aug. 4, 2026, seeking to fund implementation projects that promote the uptake of peer-reviewed findings from specific PCORI-funded patient-centered comparative clinical effectiveness research (CER) in the context of the body of related evidence. This PFA is an open competition opportunity for principal investigators to propose implementation projects that move evidence toward practical use in improving health care and health outcomes. Applicants may propose projects with budgets up to $1.8 million in total direct costs.

PCORI seeks to fund implementation projects that incorporate active, multicomponent strategies that will lead to uptake and integration of evidence generated by PCORI-funded research in practice settings. Implementation should target specific end users with a clear interest in — and ability to benefit from — the evidence. Proposed implementation projects will adapt findings as needed to facilitate uptake in the proposed settings and accomplish scale-up to reach larger numbers and/or scale-out to reach broader populations and settings. Applicants must demonstrate commitment and buy-in — including from leadership as well as frontline staff critical to the success of the project — from proposed implementation sites across multiple health systems, such that they provide a supportive context and infrastructure for undertaking the proposed project. In addition, projects should involve regional and national stakeholder organizations positioned to extend uptake in broader venues.  

Applications must be guided by an established conceptual model or framework and, where possible, by evidence regarding effective strategies for implementing evidence-based practices and interventions. Additionally, applications must include a rigorous evaluation plan that documents the successful execution of the implementation approach and the impact of the project on health care and health outcomes as feasible and appropriate within the project scope.

The Childhood Asthma in Urban Settings Clinical Research Network (CAUSE) aims to enhance asthma prevention and treatment in economically disadvantaged pediatric populations. Funded by the NIH, CAUSE supports multi-site clinical studies to identify innovative strategies and treatment targets for asthma. Utilizing systems biology, the network seeks to discover specific disease endotypes suitable for new therapeutic approaches, addressing the high burden of asthma in urban settings.

The Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, supported by the National Institute of Allergy and Infectious Diseases (NIAID), aims to enhance research on asthma and related allergic diseases. This initiative fosters multi-center, multidisciplinary research to explore disease mechanisms and treatment responses. By promoting clinical trials and observational studies, the AADCRC seeks to advance understanding and improve interventions for conditions such as asthma and food allergies, ultimately benefiting public health.

The US Flu Vaccine Effectiveness (VE) Network aims to enhance the effectiveness of vaccines against influenza and other respiratory pathogens, which are significant contributors to morbidity and mortality. This funding opportunity invites proposals for surveillance studies, including annual VE assessments, acute respiratory illness tracking, household transmission research, and immunogenicity studies. Applicants can apply for either Component A or B, with the option to include additional components based on their primary selection.

Quality Improvement Grant Request for Proposals

Optimizing Maternal RSV Immunization Delivery: A Systems-Based Quality Improvement Initiative to Improve Uptake, Equity, and Newborn Outcomes

Pfizer, in collaboration with the Society for Maternal-Fetal Medicine (SMFM), is pleased to announce a competitive grant opportunity to support independent Quality Improvement (QI) initiatives focused on advancing maternal immunization, with a specific emphasis on Respiratory Syncytial Virus (RSV) vaccination during pregnancy.

This initiative builds upon insights generated from the Maternal Immunization Needs Assessment (MINA) project, a multi-stakeholder collaboration that identified persistent clinical, behavioral, and system-level gaps in the delivery and uptake of maternal vaccines.

We seek to fund projects that implement measurable, evidence-based interventions to improve real-world delivery of maternal RSV immunization across healthcare systems and care settings. Proposed initiatives should aim to optimize access, strengthen provider–patient communication training and tools, enhance care coordination, and address structural and behavioral barriers impacting vaccine uptake and equity.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in clinical practice or care as outlined in the specific RFP.

For all QI grants, the applicant (and ultimately the grantee) will be solely responsible for the design, implementation, and conduct of the proposed initiative. Pfizer will have no involvement in project development, execution, or outcomes.

The ARS New Investigator Research Grant aims to support innovative research in rhinology, including basic, translational, and clinical projects. The funding period is non-renewable and lasts up to 24 months. Eligible candidates include American Rhinologic Society members who have completed residency and lack significant prior funding. The number of grants awarded is contingent upon the merit of applications received, as determined by the ARS Board of Directors. This grant provides a unique opportunity for emerging researchers in the field.